Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J68D | ISIN: CNE100001M79 | Ticker-Symbol: 08HH
Tradegate
31.03.25
15:39 Uhr
1,724 Euro
-0,069
-3,85 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,7721,84322:06
1,7501,84722:02

Aktuelle News zur SHANGHAI FOSUN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16:36FOSUN PHARMA (02196): CONNECTED TRANSACTION - ENTERING INTO THE SHARE SUBSCRIPTION AGREEMENT1
DoShanghai Fosun Pharmaceutical reports FY results5
MiFOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK9
MiFosun Pharma Announces 2024 Annual Results226Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai...
► Artikel lesen
DiFOSUN PHARMA (02196): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20247
SHANGHAI FOSUN PHARMACEUTICAL Aktie jetzt für 0€ handeln
DiFOSUN PHARMA (02196): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 20241
DiFOSUN PHARMA (02196): VOLUNTARY ANNOUNCEMENT - REGISTRATION OF MEDIUM TERM NOTES AND SUPER SHORT-TERM COMMERCIAL PAPERS2
14.03.Fosun Pharma verkauft Anteil an Krankenhausgruppe für 124,08 Mio. US-Dollar an Warburg Pincus - Nikkei4
14.03.Fosun Pharma offloads $124m stake in hospital group to Warburg Pincus - Nikkei18
14.03.China's Fosun Pharma to Sell United Family Healthcare to Calcite Gem for USD124 Million10
13.03.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF DRUG CLINICAL TRIAL OF A SUBSIDIARY4
13.03.FOSUN PHARMA (02196): DATE OF BOARD MEETING6
06.03.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION7
04.03.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF VACCINE CLINICAL TRIAL OF A SUBSIDIARY10
04.03.Raziel Therapeutics: Raziel and Fosun Pharma (by JuveStar an affiliate company of Fosun Pharma) Initiate Phase 3 Registration Trial in China for Submental Fat Reduction ("double chin")383REROVOT, Israel, March 3, 2025 /PRNewswire/ -- Raziel Therapeutics, a pharmaceutical company developing next-generation novel prescription products for the medical aesthetics market, announces...
► Artikel lesen
27.02.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF DRUG CLINICAL TRIAL OF A SUBSIDIARY3
26.02.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY1
26.02.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION1
26.02.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A LICENSED PRODUCT2
20.02.FOSUN PHARMA (02196): CONNECTED TRANSACTION - ENTERING INTO THE CAPITAL INCREASE AGREEMENT9
Seite:  Weiter >>
60 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1